Selleck Chemicals is a global leader in the life sciences sector, specializing in the development and supply of over 120,000 pathway inhibitors and more than 8,000 bioactive compounds, including FDA-approved molecules. Established in 2010, the company has transformed from a specialized supplier into a trusted partner for researchers around the world. Selleck Chemicals is dedicated to advancing drug discovery by providing rigorously validated chemical tools that help scientists unlock the complexities of biology with confidence.

The company offers a diverse range of products, including primary antibodies, biosimilar antibodies, and extensive compound libraries tailored for high-throughput screening and target validation. With a strong commitment to quality, each batch of their products undergoes meticulous verification through NMR, HPLC, and stringent stability tests, ensuring reliability. Selleck Chemicals maintains a global presence with strategic hubs in the United States, Germany, Japan, and China, facilitating quick delivery and local support to meet the needs of the scientific community. Their mission is to bridge the gap between biological research and future therapeutic solutions, fostering innovation in biomedical research.